Display Post Content

NVIDIA Clara - Intelligent Compute Engine for Healthcare and Life Sciences




Deep Learning research in Medical Imaging is booming with more efficient and improved approaches being developed to enable AI-assisted workflows.  Today, most of this AI research is being done in isolation and with limited datasets which may lead to overly simplified models. Even when a fully validated model is available, it is a challenge to deploy the algorithm in a local environment. With the latest release of Clara AI for Medical Imaging now data scientists, researchers and software developers have the necessary tools, APIs and development framework to train and deploy AI workflows.

Clara Train and Deploy SDKs provide Data Scientists and Radiologists with the tools to build, manage, and deploy AI workflows in medical imaging. Clara Train SDK includes APIs to add AI Assisted annotation to any medical viewer and provides a training framework optimized to train AI models for Medical Imaging. Clara Deploy SDK provides a container based development & deployment framework for building AI accelerated medical imaging workflows that can interface in a hospital infrastructure.

NVIDIA is co-hosting a free full-day workshop with the Sydney Neuroimaging Analysis Centre and the Brain and Mind Centre on using artificial intelligence tools for medical imaging research and clinical tasks. This workshop provides the perfect opportunity for students, scientists, and clinicians who are new to artificial intelligence and would like to start harnessing its power for diagnosing and treating various diseases. Examples include AI image processing and automatic lesion delineation for the brain, lungs, liver, prostate, and other organs.

Registration is now OPEN via the following link:


Location: Room 502 Brain and Mind Centre, 94 Mallett Street Camperdown, NSW 2050

Time: Wed, August 28, 2019        8:30AM – 4:00 PM AEST

Free morning tea, lunch, and afternoon tea are provided.  


logo_transparent_blue.png       sm-Nvidia_image_logo.svg.png         The-University-of-Sydney-Brain-and-Mind-Centre.png    

Sydney Neuroimaging Analysis Centre (SNAC) secures A$2.36 million Australian Government CRC-P Grant to transform Clinical Neuroimaging with AI.




·      SNAC is the lead participant in a successful CRC-P grant application: AI: new smarts for the medical imaging industry

·      The CRC-P grant provides A$2.36 million funding, with additional matched cash and in-kind participant funding.

·      Together with national imaging provider I-MED Radiology Network (I-MED) and the University of Sydney’s Brain and Mind Centre, SNAC will develop, implement and commercialise clinically meaningful AI algorithms in the clinical and clinical trials neuroimaging space.


Sydney Neuroimaging Analysis Centre (SNAC) is pleased to announce its recent success in securing support for its Artificial Intelligence in Neuroimaging project through the Australian Government’s Cooperative Research Centres (CRC) Programme.  As the lead participant, SNAC has been awarded a A$2.36 million grant, with matched cash and in-kind funding from the project participants, including SNAC, I-MED and the University of Sydney’s Brain and Mind Centre.


The Cooperative Research Centres (CRC) Programme is administered by AusIndustry, a division within the Department of Industry, Innovation and Science. The CRC Programme is a competitive, merit based grant programme that supports industry-led and outcome-focused collaborative research partnerships between industry, researchers and the community.


Dr Tim Wang PhD, Director of Operations for SNAC, said “The provision of CRC-P funding will significantly accelerate the expansion of SNAC’s neuro-imaging biomarker portfolio, enhance clinical trials of emerging therapies for neurological disorders such as multiple sclerosis and, through our partnership with I-MED, transform diagnostic neuroimaging”


“Partnership with the Computational Neuroscience Team at the University of Sydney’s Brain and Mind Centre, led by neurologist Professor Michael Barnett and AI expert Professor Dacheng Tao, is a pivotal strength of the project”.


SNAC specialises in the provision of regulatory-compliant neuroimaging analysis to the pharmaceutical industry and in particular the development of novel neuroimaging biomarkers and their implementation in Phase 2-4 clinical trials.  SNAC also works closely with academics in imaging science and clinical medicine to further research into neurological disease.


For more information please contact:   


Dr Tim Wang, Director of Operations

Email: tim@snac.com.au

Web: snac.com.au


Here you will find the latest news, tweets, posts and press releases about SNAC and our collaborators. If you like what you see, please be sure to ‘like’ or repost!